Sources | Names Used |
---|---|
CTRPv2 | selumetinib:piperlongumine (8:1 mol/mol) |
PharmacoGx | selumetinib:piperlongumine (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TTBK2 | CTRPv2 | pan-cancer | AAC | -0.15 | 7e-05 |
mRNA | NRROS | CTRPv2 | pan-cancer | AAC | 0.18 | 7e-05 |
mRNA | GSN | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |
mRNA | P2RY2 | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |
mRNA | CRLF3 | CTRPv2 | pan-cancer | AAC | -0.16 | 7e-05 |
mRNA | PRY | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |
mRNA | TNFAIP8L2 | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-05 |
mRNA | USP28 | CTRPv2 | pan-cancer | AAC | -0.14 | 8e-05 |
mRNA | PYGB | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-05 |
mRNA | CAPN3 | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-05 |